Recognition benchmarks disability workplace inclusion against other companies

Discover the latest trends and emerging strategies to manage rising medical benefit specialty drug spend.

From cutting-edge system solutions to powerful stakeholder partnerships, the Medicaid Enterprise Systems Conference delivered key insights and connections that will shape health care modernization...

Jared Scripture, health outcomes scientist, shares more about the study “Leveraging Publicly Available SDOH Measures to Segment Members and Quantify Differences in Diabetic Medication Adherence: A...

Jessica Johnson, clinical consultant at Prime, shares some tips to stay safe

AMCP Nexus offers opportunity to nurture next generation of managed care leaders

Members on cancer care journey laud Prime’s integrated clinic-to-pharmacy experience

Three studies to be recognized with awards

Prime leaders discuss rebates, reporting and other state issues at hybrid conference in Chicago.

Experts in Medicaid pharmacy delivery engage in timely discussion of states’ access and cost challenges and offer Prime’s solutions to fill resource gaps and improve health outcomes for people...

Job-seeking platform recognizes Prime’s leadership in championing flexible work

Joseph Leach, M.D., senior vice president and chief medical officer at Prime Therapeutics/Magellan Rx Management, shares more about the RTBC electronic prescription decision support tool

Prime’s IntegratedRx® – Cystic Fibrosis product earns 94% member satisfaction rate

Prime Therapeutics residents, Almina Gomez and Kathryn Makay, shared their research and experiences at annual managed care pharmacy event 

Reprinted with AIS Health permission from the November 2024 issue of Radar on Specialty Pharmacy

Prime Therapeutics offers holistic and data-driven solutions to manage drug costs and simplify the patient experience for those with hemophilia and other blood disorders

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies

Prime celebrates 25th anniversary, and Magellan Rx celebrates 10th anniversary

In late 2023, the FDA approved a new treatment regimen for urothelial cancer that represents a “paradigm change,” according to one industry expert

Nicole Grevenitz, director of clinical account services, shares more from the research study “Promoting Health Equity Through Enhanced, Personalized Digital Outreach.”

Meredith Delk, senior vice president and general manager of state government solutions at Prime Therapeutics, shares more about the important role women play in our world today

Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”

A look at the specialty landscape and how Prime delivers value to employers

What works and what doesn’t

Magellan Rx's businesses includes a 1.7-million member PBM. The deal is struck amid a long-time trend toward consolidation in the pharmacy benefit management industry

cover image for Trending Topics & Drug Approvals: June 2025 Your source for the latest drug information highlights Prime Therapeutics /trending-topics-drug-approvals-june-2025-1 Prime Therapeutics’...

Formulary Watch: The new program, which begins in January 2025, provides members of Prime Therapeutics support for navigating utilization management requirements and finding financial assistance.

Event will feature David Lassen, chief clinical officer

Join Prime/Magellan Rx CEO Mostafa Kamal and Capital Rx CEO AJ Loiacono for their presentation, “Transformation within the pharmacy benefits ecosystem.”

Prime experts will dive into the latest trends in spend, disease categories and cost management strategies for payers.

Leslie Dickens, VP of operations and continuous improvement, joins experts in Dallas, Texas, to discuss the role and future of contact centers

Join us on Aug. 8 for a virtual conversation on how ERGs and BRGs can create more inclusive workplaces at Disability:IN Minnesota's August Member Meeting.

Prime moves up one spot to No. 2 in annual ranking

Prime experts will dive into the latest trends in spend, disease categories and cost management strategies for payers.

Dinesh Kandanchatha, chief information and technology officer at Prime Therapeutics, will join panelists in a Nov. 11 discussion about pressing issues facing health care

Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty...

Lowest net cost strategy helps enable provider, patient choice; helps ensure optimal, cost-effective therapy for complex inflammatory conditions.

Upcoming webinar on Nov. 6 shares more about Prime’s industry-leading ASHP-accredited PGY1 residency program

NCQA has awarded Prime Therapeutics LLC certification in Pharmacy Benefits

Prerak Parikh, PharmD, director of specialty clinical solutions at Prime Therapeutics/Magellan Rx Management, is named among 14 national 2024 Emerging Leaders in Healthcare Award recipients.